MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-13-2026
Second Sight Medical Products Total Current Liabilities 2011-2026 | EYES
Annual Total Current Liabilities Second Sight Medical Products
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.6 M | 5.99 M | 5.72 M | 6.82 M | 2.09 M | 5.13 M | 6.96 M | 7.6 M | 6.62 M | 5.66 M | 7.98 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.98 M | 2.09 M | 6.11 M |
Total Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cutera
CUTR
|
87.7 M | - | -10.19 % | $ 1.99 M |  USA |
 |
EDAP TMS S.A.
EDAP
|
37.8 M | - | - | $ 162 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.1 M | - | - | $ 1.77 B | USA |
 |
Avinger
AVGR
|
19.3 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
45.8 M | - | - | $ 3.31 B | USA |
 |
Eargo
EAR
|
25.3 M | - | - | $ 10.2 M | USA |
 |
Allied Healthcare Products
AHPI
|
5.98 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.05 M | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
10.8 M | $ 13.46 | 0.15 % | $ 381 M | USA |
 |
Apollo Endosurgery
APEN
|
39.5 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
219 M | $ 8.18 | -1.27 % | $ 1.23 B | USA |
 |
Aziyo Biologics
AZYO
|
25.1 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
42.8 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
19.7 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
14.1 M | - | - | $ 16.4 M | USA |
 |
IRIDEX Corporation
IRIX
|
13.2 M | $ 1.17 | 4.02 % | $ 19.8 M | USA |
 |
Cardiovascular Systems
CSII
|
40 M | - | 0.15 % | $ 844 M | USA |
 |
Helius Medical Technologies
HSDT
|
3.02 M | $ 1.7 | 10.56 % | $ 37.5 M | USA |
 |
CryoLife, Inc.
CRY
|
60.5 M | - | -4.14 % | $ 702 M | USA |
 |
Cytosorbents Corporation
CTSO
|
9.71 M | $ 0.44 | 9.4 % | $ 27.4 M | USA |
 |
LivaNova PLC
LIVN
|
808 M | $ 79.48 | 0.11 % | $ 4.34 B |  Britain |
 |
Pulmonx Corporation
LUNG
|
20.1 M | $ 1.26 | -7.66 % | $ 51.3 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
46.2 M | $ 18.25 | 2.41 % | $ 428 M | USA |
 |
Delcath Systems
DCTH
|
11 M | $ 11.76 | 0.34 % | $ 421 M | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.19 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
18 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
17.3 M | - | - | $ 462 M | USA |
 |
Orthofix Medical
OFIX
|
170 M | $ 9.15 | -1.77 % | $ 362 M |  Curacao |
 |
LENSAR
LNSR
|
40.6 M | $ 5.79 | -0.6 % | $ 69.2 M | USA |
 |
Dynatronics Corporation
DYNT
|
8.24 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
10.5 M | $ 37.54 | 1.08 % | $ 317 M | USA |
 |
MiMedx Group
MDXG
|
64.3 M | $ 3.69 | 2.36 % | $ 545 M | USA |
 |
Profound Medical Corp.
PROF
|
6.08 M | $ 6.77 | 2.11 % | $ 205 M |  Canada |
 |
Butterfly Network
BFLY
|
65.1 M | $ 5.67 | 2.26 % | $ 1.4 B | USA |
 |
Intersect ENT, Inc.
XENT
|
44.2 M | - | - | $ 955 M | USA |
 |
Myomo
MYO
|
8.35 M | $ 1.34 | 16.52 % | $ 56.1 M | USA |
 |
GBS
GBS
|
5.35 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
498 M | $ 76.85 | -4.4 % | $ 10.4 B | USA |
 |
Insulet Corporation
PODD
|
680 M | $ 147.95 | -1.17 % | $ 10.4 B | USA |
 |
CONMED Corporation
CNMD
|
315 M | $ 33.67 | -3.18 % | $ 1.04 B | USA |
 |
Inspire Medical Systems
INSP
|
96.1 M | $ 40.82 | -4.4 % | $ 1.2 B | USA |
 |
Integer Holdings Corporation
ITGR
|
232 M | $ 90.63 | -0.38 % | $ 3.15 B | USA |
 |
Invacare Corporation
IVC
|
220 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.81 B | $ 85.78 | 0.79 % | $ 50.2 B | USA |
 |
Sintx Technologies
SINT
|
3.73 M | $ 2.19 | - | $ 6.07 M | USA |